MedPath

The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)

Phase 4
Conditions
IBS
Interventions
Dietary Supplement: PHGG
Dietary Supplement: Maltodextrin
Registration Number
NCT01779765
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

This study objective is to assess the short and long term effects of partially hydrolyzed guar gum (PHGG) administration on clinical symptoms of IBS and quality of life of these patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Fulfillment of the Rome III criteria for IBS.
  • Aged 20-68 years at the time of screening.
  • Provision of written informed consent.
  • Commitment of availability throughout the 6 months study period.
Exclusion Criteria
  • Major abdominal surgery in the past.
  • The presence of any active (organic)GI disease.
  • Past or present major medical or psychiatric illness.
  • Any concomitant disease.
  • Alarming symptoms (rectal bleeding, weight loss, etc.)
  • Pregnancy.
  • Family history of colorectal carcinoma or inflammatory bowel disease (IBD).
  • Abnormal laboratory studies (blood biochemistry , liver enzymes,complete blood count), abnormal thyroid function.
  • Non-adjusted diet in the case of lactose or gluten intolerance.
  • Recent travel to regions with endemic parasitic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PHGGPHGG2.5gr per day for the first week and then 5gr per day for 11 weeks.
MaltodextrinMaltodextrin2.5gr per day for the first week and then 5gr per day for 11 weeks.
Primary Outcome Measures
NameTimeMethod
Improvement in IBS score.2 years

IBS scoring - Francis severity IBS score.

Secondary Outcome Measures
NameTimeMethod
Quality questionnaire2 years

Quality of life - by the IBS - quality of life questionnaire - Drossman Patrick.

Trial Locations

Locations (1)

Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath